Tanrikulu Y - Search Results

1

From molecular shape to potent bioactive agents I: bioisosteric replacement of molecular fragments.

Proschak E, Zettl H, Tanrikulu Y, Weisel M, Kriegl JM, Rau O, Schubert-Zsilavecz M, Schneider G. Proschak E, et al. Among authors: tanrikulu y. ChemMedChem. 2009 Jan;4(1):41-4. doi: 10.1002/cmdc.200800313. ChemMedChem. 2009. PMID: 19058279 No abstract available.

2

Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenase.

Hofmann B, Franke L, Proschak E, Tanrikulu Y, Schneider P, Steinhilber D, Schneider G. Hofmann B, et al. Among authors: tanrikulu y. ChemMedChem. 2008 Oct;3(10):1535-8. doi: 10.1002/cmdc.200800153. ChemMedChem. 2008. PMID: 18688907 No abstract available.

3

From molecular shape to potent bioactive agents II: fragment-based de novo design.

Proschak E, Sander K, Zettl H, Tanrikulu Y, Rau O, Schneider P, Schubert-Zsilavecz M, Stark H, Schneider G. Proschak E, et al. Among authors: tanrikulu y. ChemMedChem. 2009 Jan;4(1):45-8. doi: 10.1002/cmdc.200800314. ChemMedChem. 2009. PMID: 19058280 No abstract available.

4

Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.

Tanrikulu Y, Proschak E, Werner T, Geppert T, Todoroff N, Klenner A, Kottke T, Sander K, Schneider E, Seifert R, Stark H, Clark T, Schneider G. Tanrikulu Y, et al. ChemMedChem. 2009 May;4(5):820-7. doi: 10.1002/cmdc.200800443. ChemMedChem. 2009. PMID: 19343764

5

Potent inhibitors of 5-lipoxygenase identified using pseudoreceptors.

Rödl CB, Tanrikulu Y, Wisniewska JM, Proschak E, Schneider G, Steinhilber D, Hofmann B. Rödl CB, et al. Among authors: tanrikulu y. ChemMedChem. 2011 Jun 6;6(6):1001-5. doi: 10.1002/cmdc.201100059. Epub 2011 Apr 19. ChemMedChem. 2011. PMID: 21506275 No abstract available.

6

Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.

Tanrikulu Y, Schneider G. Tanrikulu Y, et al. Nat Rev Drug Discov. 2008 Aug;7(8):667-77. doi: 10.1038/nrd2615. Epub 2008 Jul 18. Nat Rev Drug Discov. 2008. PMID: 18636071 Review.

7

Voyages to the (un)known: adaptive design of bioactive compounds.

Schneider G, Hartenfeller M, Reutlinger M, Tanrikulu Y, Proschak E, Schneider P. Schneider G, et al. Among authors: tanrikulu y. Trends Biotechnol. 2009 Jan;27(1):18-26. doi: 10.1016/j.tibtech.2008.09.005. Epub 2008 Nov 10. Trends Biotechnol. 2009. PMID: 19004513 Review.

8

Structure-based pharmacophore screening for natural-product-derived PPARgamma agonists.

Tanrikulu Y, Rau O, Schwarz O, Proschak E, Siems K, Müller-Kuhrt L, Schubert-Zsilavecz M, Schneider G. Tanrikulu Y, et al. Chembiochem. 2009 Jan 5;10(1):75-8. doi: 10.1002/cbic.200800520. Chembiochem. 2009. PMID: 19067454 No abstract available.

9

Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands.

Sander K, Kottke T, Proschak E, Tanrikulu Y, Schneider EH, Seifert R, Schneider G, Stark H. Sander K, et al. Among authors: tanrikulu y. Inflamm Res. 2010 Mar;59 Suppl 2:S249-51. doi: 10.1007/s00011-009-0143-2. Inflamm Res. 2010. PMID: 20012148

10

SOMMER: self-organising maps for education and research.

Schmuker M, Schwarte F, Brück A, Proschak E, Tanrikulu Y, Givehchi A, Scheiffele K, Schneider G. Schmuker M, et al. Among authors: tanrikulu y. J Mol Model. 2007 Jan;13(1):225-8. doi: 10.1007/s00894-006-0140-0. Epub 2006 Sep 22. J Mol Model. 2007. PMID: 17024412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters